In addition, TGF-β1 can reduce leukocyte and macrophage infiltration and suppress the production of pro-inflammatory cytokines such as IL-1β and TNF-α, directly contributing to reducing inflammation and slowing the progression of DKD [21]. Here, IL1B is linked to diabetic kidney disease.